Zelminemab
CAS No. 2225850-33-7
Zelminemab( —— )
Catalog No. M36779 CAS No. 2225850-33-7
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 603 | In Stock |
|
| 10MG | 1026 | In Stock |
|
| 25MG | 1501 | In Stock |
|
| 50MG | 2009 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZelminemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionZelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
-
DescriptionZelminemab (AMG-301) is a human monoclonal antibody that inhibits PACAP type I (PAC1) receptor.
-
In Vitro——
-
In VivoAnimal Model:Sprague-Dawley rats, electricalstimulation was performed on the intact dura mater abovethe middle meningeal artery.Dosage:10 mg/kg Administration:i.v.; once Result:Induced an inhibition of stimulus-evoked nociceptive activity in the trigeminocervical com-plex (TCC).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225850-33-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain. 2018 Aug 7;19(1):64. ?
molnova catalog
related products
-
Zearalenone
Zearalenone is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. Possess oestrogenic activity in pigs cattle and sheep with low acute toxicity. Causes precocious development of mammae and other estrogenic effects in young gilts.
-
Neoglycyrol
Neoglycyrol shows some cardioprotective effects .
-
Ensaculin
Ensaculin (Anseculin), a novel benzopyrone partially substituted with piperazine, showed memory-enhancing effects in passive and conditioned avoidance paradigms in normal and artificially amnesic rodents.
Cart
sales@molnova.com